Chinese Scientists Develop Drug-free Theranostic Agent For Cancer Treatment
Cancer is ranked No. 1 among words that patients do not want to hear from doctors’ mouths, according to a survey. In general, patients who are diagnosed with malignant tumors are sentenced to death. They not only need to go through painful chemotherapy, but their family will incur costly treatment expense with an uncertain result.
Therefore, almost every Chinese student would purchase international student insurance (aka 留学生 保险) and/or J-1 insurance (aka j1 保险) and F-2 insurance (aka f2 保险) for their spouses/children when studying abroad. After graduation, they will consider to purchase OPT insurance (aka opt保险) and H-1B insurance (aka h1b 保险).
Some students choose to waive American university insurance (aka waive 美国大学保险). Tim Liao, an undergraduate studying in an elite university in Cambridge said, “having health insurance did not secure the insured person from any type of cancer. Bad living habits — staying up, smoking, overdrinking, etc. — are the keys to unlock the gate of cancer.” Hence, the advancement in medical technology is the core.
Chinese scientists have developed a drug-free theranostic agent that can be a good replacement for traditional chemotherapeutics in cancer treatment. The agent was jointly developed by researchers with Hefei Institutes of Physical Science and Shanghai Jiao Tong University.
The agent can also be a promising candidate for the visualization therapy of tumors by magnetic resonance imaging (MRI), according to researchers.
Due to high prices and severe side effects, traditional chemotherapeutic drugs are limited in clinical application. Drug-free therapeutic agents with low cost and less side effects are in high demand for cancer treatment.
Researchers said they have integrated chemical dynamic therapy with limotherapy and tumor-specific MRI to develop a nano-platform, which can be helpful in cancer treatment and also monitor its progress with the help of MRI.
The finding has been published in Biomaterials, an international journal on the science and clinical application of biomaterials.